Rapporto sull’analisi delle dimensioni del mercato della consegna di farmaci farmaceutici e dell’analisi delle quote | Previsioni 2031

  • Report Code : TIPRE00007628
  • Category : Pharmaceuticals
  • Status : Published
  • No. of Pages : 197
Buy Now

Il mercato della consegna di farmaci dovrebbe raggiungere 2.296.170,9 milioni di dollari nel 2027 da 1.403.082,9 milioni di dollari nel 2019. Si stima che il mercato crescerà a un CAGR del 6,6% nel 2020-2027 .

I sistemi di somministrazione di farmaci sono le tecnologie utilizzate principalmente per la somministrazione controllata o mirata di vari agenti terapeutici per trattare varie malattie o migliorare la salute dei pazienti. I sistemi di somministrazione di farmaci sono dispositivi medici utilizzati per iniettare farmaci o sostanze chimiche nel corpo. Alcuni dei sistemi di somministrazione di farmaci disponibili sul mercato includono transmucoso, orale, polmonare, iniettabile, topico, nasale, impiantabile e oculare.

Mercati regionali redditizi per la distribuzione di farmaci

Approfondimenti di mercato

Crescente prevalenza di malattie infettive e croniche

La prevalenza delle malattie infettive, in particolare delle malattie batteriche, è in continuo aumento in tutto il mondo. Secondo uno studio pubblicato dall'American Society for Microbiology nel 2019, il mondo segnala che ogni anno circa 1,5-4,5 milioni di infezioni sono causate da Enterobatteriaceae resistenti ai carbapenemi. Inoltre, questo gruppo di batteri porta ogni anno al ricovero ospedaliero di circa 49.000 persone negli Stati Uniti. Inoltre, secondo uno studio pubblicato dall’UNICEF, nel 2018 la polmonite ha causato la morte di circa 1.755.000 bambini di età <5; inoltre, circa 1.200.000 bambini nel mondo hanno perso la vita a causa della diarrea. Tale prevalenza in crescita esponenziale delle malattie infettive guida il consumo di farmaci, che alla fine guida la crescita del mercato della distribuzione di farmaci.

Tra le condizioni croniche, il cancro e il diabete sono la principale causa di mortalità in tutto il mondo. Ad esempio, secondo uno studio condotto dall’American Cancer Society (ACS), gli Stati Uniti hanno segnalato circa 1.735.350 nuovi casi di cancro nel 2018. Inoltre, secondo l’International Diabetes Federation (IDF), circa 46 milioni di americani soffrivano di diabete nel 2017. e si prevede che questo numero raggiungerà i 62 milioni entro il 2045. È stato inoltre menzionato che circa 425 milioni di persone in tutto il mondo convivevano con il diabete nel 2017 e si prevede che il numero raggiungerà i 629 milioni entro il 2045.

Approfondimenti sulla via di somministrazione

Il mercato della somministrazione di farmaci farmaceutici, in base alla via di somministrazione, è segmentato in somministrazione di farmaci per via orale, somministrazione di farmaci iniettabili, somministrazione di farmaci topici, somministrazione di farmaci oculare, somministrazione di farmaci polmonare, somministrazione di farmaci nasali, somministrazione di farmaci transmucosali e somministrazione di farmaci impiantabili. Il segmento della somministrazione di farmaci iniettabili ha detenuto la quota maggiore del mercato nel 2019. Tuttavia, si prevede che il segmento della somministrazione di farmaci topici registrerà il CAGR più elevato del mercato durante il periodo di previsione.

Mercato della consegna dei farmaci farmaceutici, per via di somministrazione - 2019 e 2027

Applications Insights

Sulla base delle applicazioni, il mercato della consegna di farmaci è stato segmentato in malattie infettive, cancro, malattie cardiovascolari, diabete , malattie respiratorie, disturbi del sistema nervoso centrale, malattie autoimmuni e altre malattie. Il segmento del cancro ha detenuto la quota maggiore del mercato nel 2019; tuttavia, si stima che il segmento delle malattie infettive registrerà il CAGR più elevato durante il periodo di previsione.

Approfondimenti sull'utente finale

Sulla base dell'utente finale , il mercato della consegna dei farmaci è stato segmentato in ospedali, strutture di assistenza domiciliare, ASC/cliniche e altri utenti finali. Il segmento ospedaliero ha detenuto la quota maggiore del mercato nel 2019, mentre si stima che il segmento delle strutture di assistenza domiciliare registrerà il CAGR più elevato nel periodo 2020-2027.

Approfondimenti strategici< /h3>

Il lancio e l'approvazione dei prodotti è una strategia comunemente adottata dalle aziende per espandere la propria presenza in tutto il mondo e soddisfare la crescente domanda. Questa strategia è più comunemente adottata dagli operatori del mercato per espandere i rispettivi portafogli di prodotti.

Gli operatori che operano nel mercato della consegna di farmaci adottano la strategia di espansione per ampliare la base di clienti attraverso il mondo; inoltre implementano le strategie di collaborazioni e lanci di prodotto. Queste strategie consentono loro di mantenere il proprio marchio a livello globale. Ad esempio, nel maggio 2018, GlaxoSmithKline plc ha ricevuto l’approvazione della FDA per l’uso di Arnuity Ellipta (fluticasone furoato) per il trattamento di mantenimento dell’asma nei bambini di età inferiore a 5 anni. Si tratta di un medicinale a base di corticosteroidi inalatori (ICS) una volta al giorno.

Per via di somministrazione

  • Consegna di farmaci per via orale
  • erogazione di farmaci iniettabili
  • erogazione di farmaci per via topica
  • erogazione di farmaci oculari
  • erogazione di farmaci a livello polmonare
  • erogazione di farmaci per via nasale
  • Velocità di farmaci per via transmucosa
  • Velocità di farmaci impiantabili

Per applicazione

  • Malattie infettive
  • Cancro< /li>
  • Malattie cardiovascolari
  • Diabete
  • Malattie respiratorie
  • Disturbi del sistema nervoso centrale
  • Malattie autoimmuni
  • < li>Altre applicazioni

Per utente finale

  • Ospedali
  • Impostazioni di assistenza domiciliare
  • ASC/Cliniche< /li>
  • Altri utenti finali

Per area geografica

  • Nord America
    • Stati Uniti
    • Canada< /li>
    • Messico
  • Europa
    • Germania
    • Regno Unito
    • Francia
    • Italia
    • Spagna
  • Asia Pacifico (APAC)
    • Cina
    • India
    • Giappone
    • Corea del Sud
    • Australia
  • Medio Oriente e Africa (MEA)
    • Sud Africa
    • Arabia Saudita
    • Emirati Arabi Uniti
  • America centrale e meridionale (SCAM)
    • Brasile
    • Argentina

Profili aziendali

  • Pfizer Inc.
  • Bayer AG
  • Johnson & Johnson Services, Inc.
  • Novartis AG
  • 3M
  • Becton, Dickinson and Company
  • Sanofi
  • Merck KGaA
  • GlaxoSmithKline plc.
  • Antares Pharma
Report Coverage
Report Coverage

Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends

Segment Covered
Segment Covered

This text is related
to segments covered.

Regional Scope
Regional Scope

North America, Europe, Asia Pacific, Middle East & Africa, South & Central America

Country Scope
Country Scope

This text is related
to country scope.

Frequently Asked Questions


What does pharmaceutical drug delivery mean?

Drug delivery systems are medical devices used to inject drugs or chemicals into the body. Some of the drug delivery systems available in the market include, transmucosal, oral, pulmonary, injectable, topical, nasal, implantable, and ocular among others. Drug delivery systems are the technologies primarily used for the controlled or targeted delivery of various therapeutic agents to treat various diseases or improve the health of the patients.

What are the driving and restraining factors for the pharmaceutical drug delivery market across the globe?

The growth of the market is attributed to some key driving factors such as growing prevalence of infectious and increasing r&d spending for drug delivery devices. However, high cost of drug delivery device development is likely to pose a negative impact on the market during the forecast years.

What is the regional analysis in terms of pharmaceutical drug delivery?

The North American region holds the largest market for the pharmaceutical drug delivery. The United States held the largest market for pharmaceutical drug delivery mean market and is expected to grow due to factors such as increasing incidence of cancer along with the growing need for diagnosing, demand for chronic disease medications from pharmaceutical companies, presence of key market players and extensive R&D conducted by various academic and research institutes.

The List of Companies - Pharmaceutical Drug Delivery Market

  1. Pfizer Inc.
  2. Bayer AG
  3. Johnson & Johnson Services, Inc.
  4. Novartis AG
  5. 3M
  6. Becton, Dickinson and Company
  7. Sanofi
  8. MERCK KGaA
  9. GlaxoSmithKline plc.
  10. Antares Pharma

The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.

  1. Data Collection and Secondary Research:

As a market research and consulting firm operating from a decade, we have published and advised several client across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.

Several associations trade associates, technical forums, institutes, societies and organization are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in last 3 years are scrutinized and analyzed to understand the current market trends.

  1. Primary Research:

The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.

For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.

A typical research interview fulfils the following functions:

  • Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
  • Validates and strengthens in-house secondary research findings
  • Develops the analysis team’s expertise and market understanding

Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:

  • Industry participants: VPs, business development managers, market intelligence managers and national sales managers
  • Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.

Below is the breakup of our primary respondents by company, designation, and region:

Research Methodology

Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.

  1. Data Analysis:

Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.

  • Macro-Economic Factor Analysis:

We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.

  • Country Level Data:

Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.

  • Company Profile:

The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.

  • Developing Base Number:

Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.

  1. Data Triangulation and Final Review:

The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.

We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.

We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.

Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

Related Reports